Buy Immunic Inc Stock | IMUX Stock Price & Latest News | Public
IMUX

Immunic Inc

$0.00 (0.00%)Today
    Small Market Cap

    About IMUX

    Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-83...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.3
    -0.6
    -0.9
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.62

    Actual EPS
    Q3 2020

    Stats

    Market Cap$339,98M
    Volume23,04k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$23.39
    1 Year Low$4.19
    Open$15.34
    High$16.49
    Low$15.32

    Buy any stock with any amount of money.

    Download the App
    Download the app